Literature DB >> 23371324

Subclassification of chronic rhinosinusitis.

Joseph K Han1.   

Abstract

OBJECTIVES/HYPOTHESIS: There are variants of chronic rhinosinusitis (CRS). Therefore, the objectives of this study were to phenotype the subclasses of CRS as well as characterize their polyps with histology and cellular-intracellular biomarkers. STUDY
DESIGN: Prospective case-control study.
METHODS: Demographic data, quality-of-life (QoL) questionnaires, nasal endoscopy (NE), and computed tomography (CT) scores were obtained. CRS was divided into seven subclasses: aspirin-exacerbated respiratory disease (AERD), asthmatic sinusitis with and without allergy, nonasthmatic sinusitis with and without allergy, allergic fungal sinusitis (AFS), and cystic fibrosis (CF). Histopathologic and immunohistochemistry of nasal polyps were recorded. CD3, CD4, CD8, CD19, CD45, and CD56 data were collected. Interleukin (IL)4, IL5, IL13, IL17, and interferon (IFN)-γ were measured.
RESULTS: Eight-four subjects were in this study. Two QoL questionnaires were inadequate at distinguishing the control group from CRS. NE and CT were able to differentiate between the control group and all CRS subclasses (P<.01). Asthmatic sinusitis, AERD, and AFS had high NE and CT scores, nasal polyps, eosinophils, mast cell, and hypercellularity. Asthmatic sinusitis, nonasthmatic sinusitis, and AERD had higher CD4 cells than control group (P<.05). Even though asthmatic sinusitis and AFS are mediated by Th2, AFS had differing levels of Th2 cytokines. Each nonasthmatic sinusitis had purulence and low CT score. Each nonasthmatic sinusitis had higher CD4 cells and IFN-γ than control (P<.05). CF is associated with purulence, high CT score, high polymorphonuclear leukocytes, high plasma cells, and high mast cells.
CONCLUSIONS: Well-characterized and distinct groups of CRS have been defined for targeted treatment and research studies.
Copyright © 2013 The American Laryngological, Rhinological and Otological Society, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23371324     DOI: 10.1002/lary.23979

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  14 in total

Review 1.  Chronic rhinosinusitis phenotypes.

Authors:  John W Steinke; Larry Borish
Journal:  Ann Allergy Asthma Immunol       Date:  2016-09       Impact factor: 6.347

Review 2.  Chronic Rhinosinusitis and the Evolving Understanding of Microbial Ecology in Chronic Inflammatory Mucosal Disease.

Authors:  Michael Hoggard; Brett Wagner Mackenzie; Ravi Jain; Michael W Taylor; Kristi Biswas; Richard G Douglas
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

3.  Identification of chronic rhinosinusitis phenotypes using cluster analysis.

Authors:  Zachary M Soler; J Madison Hyer; Viswanathan Ramakrishnan; Timothy L Smith; Jess Mace; Luke Rudmik; Rodney J Schlosser
Journal:  Int Forum Allergy Rhinol       Date:  2015-02-17       Impact factor: 3.858

Review 4.  From DREAM to REALITI-A and beyond: Mepolizumab for the treatment of eosinophil-driven diseases.

Authors:  Ian D Pavord; Elisabeth H Bel; Arnaud Bourdin; Robert Chan; Joseph K Han; Oliver N Keene; Mark C Liu; Neil Martin; Alberto Papi; Florence Roufosse; Jonathan Steinfeld; Michael E Wechsler; Steven W Yancey
Journal:  Allergy       Date:  2021-09-16       Impact factor: 14.710

5.  Prognostic factors for polyp recurrence in chronic rhinosinusitis with nasal polyps.

Authors:  Junqin Bai; Julia H Huang; Caroline P E Price; Jacob M Schauer; Lydia A Suh; Regan Harmon; David B Conley; Kevin C Welch; Robert C Kern; Stephanie Shintani-Smith; Anju T Peters; Whitney W Stevens; Atsushi Kato; Robert P Schleimer; Bruce K Tan
Journal:  J Allergy Clin Immunol       Date:  2022-03-16       Impact factor: 14.290

6.  Interferon gamma causes olfactory dysfunction without concomitant neuroepithelial damage.

Authors:  Tatyana Pozharskaya; Andrew P Lane
Journal:  Int Forum Allergy Rhinol       Date:  2013-09-17       Impact factor: 3.858

7.  Interleukin-4 and interleukin-13 compromise the sinonasal epithelial barrier and perturb intercellular junction protein expression.

Authors:  Sarah K Wise; Adrienne M Laury; Elizabeth H Katz; Kyle A Den Beste; Charles A Parkos; Asma Nusrat
Journal:  Int Forum Allergy Rhinol       Date:  2014-02-07       Impact factor: 3.858

8.  Non-Eosinophilic Nasal Polyps Shows Increased Epithelial Proliferation and Localized Disease Pattern in the Early Stage.

Authors:  Dong-Kyu Kim; Hong Ryul Jin; Kyoung Mi Eun; Somasundran Mutusamy; Seong H Cho; Sohee Oh; Dae Woo Kim
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

9.  MBP-positive and CD11c-positive cells are associated with different phenotypes of Korean patients with non-asthmatic chronic rhinosinusitis.

Authors:  Dong-Kyu Kim; Min-Hyun Park; Dong-Yeop Chang; Kyung Mi Eun; Hyun-Woo Shin; Ji-Hun Mo; Eui-Cheol Shin; Hong Ryul Jin; Sue Shin; Eun Youn Roh; Doo Hee Han; Dae Woo Kim
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

Review 10.  Subtyping of polyposis nasi: phenotypes, endotypes and comorbidities.

Authors:  Michael Koennecke; Ludger Klimek; Joaquim Mullol; Philippe Gevaert; Barbara Wollenberg
Journal:  Allergo J Int       Date:  2018-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.